{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:19:02Z","timestamp":1777879142006,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH -11004029"],"award-info":[{"award-number":["NCKUH -11004029"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["109-2314-B-006-089-MY3"],"award-info":[{"award-number":["109-2314-B-006-089-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110-2314-B-675-001"],"award-info":[{"award-number":["110-2314-B-675-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110-2320-B-006-024"],"award-info":[{"award-number":["110-2320-B-006-024"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW 110-TDU-B-211-124003"],"award-info":[{"award-number":["MOHW 110-TDU-B-211-124003"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jfma.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:46:19Z","timestamp":1658364379000},"page":"2608-2616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reappraisal of the clinical role of metronidazole therapy for Clostridioides difficile infection in Taiwan: A multicenter prospective study"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-563X","authenticated-orcid":false,"given":"Jen-Chieh","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4949-2742","authenticated-orcid":false,"given":"Ching-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Wei","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-9839","authenticated-orcid":false,"given":"Pei-Jane","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Ti","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Pin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2022.07.004_bib1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jmii.2021.01.003","article-title":"Molecular characterization of Clostridioides difficile ribotype 027 in a major Chinese hospital","volume":"54","author":"Zhang","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jmii.2020.07.012","article-title":"Severe Clostridium difficile infections in intensive care units: diverse clinical presentations","volume":"54","author":"Lee","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib3","first-page":"53578","article-title":"Increased age and proton pump inhibitors are associated with severe Clostridium difficile infections in children","author":"Chang","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jmii.2019.07.004","article-title":"Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: vary by hospitalized duration","volume":"54","author":"Hung","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jmii.2021.02.002","article-title":"Clostridioides difficile infection in patients with hematological malignancy: a multicenter study in Taiwan","volume":"54","author":"Hung","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jmii.2019.08.009","article-title":"Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: establishment and implementation","volume":"52","author":"Lin","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jmii.2020.02.002","article-title":"Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan","volume":"53","author":"Wu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jmii.2019.08.004","article-title":"Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in northern Taiwan","volume":"54","author":"Chang","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib9","article-title":"The role of Toll-like receptor-2 in Clostridioides difficile infection: evidence from a mouse model and clinical patients","volume":"12","author":"Lai","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jfma.2022.07.004_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jmii.2021.06.002","article-title":"Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - a possibility or an improbability?","volume":"54","author":"Chiu","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"10.1016\/j.jfma.2022.07.004_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00799-21","article-title":"Clinical significance of toxigenic Clostridioides difficile growth in stool cultures during the era of nonculture methods for the diagnosis of C. difficile infection","volume":"9","author":"Lee","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jfma.2022.07.004_bib12","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib14","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/infdis\/jiv256","article-title":"Loss of microbiota-mediated colonization resistance to Clostridium difficile infection with oral vancomycin compared with metronidazole","volume":"212","author":"Lewis","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2217\/fmb-2019-0157","article-title":"Potential impact of removing metronidazole from treatment armamentarium of mild acute Clostridioides difficile infection","volume":"14","author":"Zilberman-Itskovich","year":"2019","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jfma.2022.07.004_bib16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/cid\/ciy1077","article-title":"What Is the role for metronidazole in the treatment of Clostridium difficile infection? Results from a national cohort study of veterans with initial mild disease","volume":"69","author":"Appaneal","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3346\/jkms.2011.26.10.1258","article-title":"Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital","volume":"26","author":"Kim","year":"2011","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.jfma.2022.07.004_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cmi.2018.06.020","article-title":"Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes","volume":"25","author":"Falcone","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/cid\/civ749","article-title":"Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort","volume":"61","author":"Abou Chakra","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2047-2994-2-21","article-title":"Epidemiology of Clostridium difficile infection in Asia","volume":"2","author":"Collins","year":"2013","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jfma.2022.07.004_bib21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2147\/IDR.S162874","article-title":"Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic Clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan","volume":"11","author":"Hung","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jfma.2022.07.004_bib22","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2022.07.004_bib23","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2022.07.004_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0014-2565(06)72875-2","article-title":"[Validity of Framingham criteria as a clinical test for systolic heart failure]","volume":"206","author":"Jimeno Sainz","year":"2006","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.jfma.2022.07.004_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib26","first-page":"7098","article-title":"The first case of severe Clostridium difficile ribotype 027 infection in Taiwan","author":"Hung","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jfma.2022.07.004_bib27","series-title":"Performance standards for antimicrobial susceptibility testing; 31th informational supplement","year":"2021"},{"key":"10.1016\/j.jfma.2022.07.004_bib28","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.trstmh.2006.01.009","article-title":"Prevalence of Clostridium difficile in the environment in a rural community in Zimbabwe","volume":"100","author":"Simango","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jfma.2022.07.004_bib29","series-title":"Breakpoint tables for interpretation of MICs and zone diameters","year":"2021"},{"issue":"Suppl 2","key":"10.1016\/j.jfma.2022.07.004_bib30","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1093\/cid\/cis340","article-title":"Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis","volume":"55","author":"Bauer","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cardfail.2016.06.005","article-title":"Hospitalized patients with heart failure and common bacterial infections: a nationwide analysis of concomitant Clostridium difficile infection rates and in-hospital mortality","volume":"22","author":"Mamic","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.jfma.2022.07.004_bib32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jamcollsurg.2013.05.028","article-title":"Clostridium difficile colitis in the United States: a decade of trends, outcomes, risk factors for colectomy, and mortality after colectomy","volume":"217","author":"Halabi","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jfma.2022.07.004_bib33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MCG.0b013e31826af6fd","article-title":"Acute kidney injury is an independent marker of severity in Clostridium difficile infection: a nationwide survey","volume":"47","author":"Khanna","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jfma.2022.07.004_bib34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s10096-018-3344-1","article-title":"Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)","volume":"37","author":"Vehreschild","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/jgh.14064","article-title":"Acute kidney injury impact on inpatient mortality in Clostridium difficile infection: a national propensity-matched study","volume":"33","author":"Charilaou","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2022.07.004_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/jocmr3531w","article-title":"Risk factors associated with recurrent Clostridium difficile infection","volume":"11","author":"Dharbhamulla","year":"2019","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.jfma.2022.07.004_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bjid.2015.03.006","article-title":"A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity","volume":"19","author":"Di","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jfma.2022.07.004_bib38","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.27.10.1169","article-title":"Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile","volume":"27","author":"Bolton","year":"1986","journal-title":"Gut"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622002583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664622002583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:36:10Z","timestamp":1777592170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664622002583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0929664622002583"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2022.07.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reappraisal of the clinical role of metronidazole therapy for Clostridioides difficile infection in Taiwan: A multicenter prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}